glp 1 side effects teeth America's Weight-Loss Drugs Boom: The Growing Link Between GLP-1 Use and Oral Health Concerns Does GLP-1 therapy actually cause

Protecting GLP-1 Therapies, Protecting Business GLP-1 therapies are a breakthrough in chronic disease treatment

NICE guidelines for type 2 diabetes (NG28) and obesity do not include berberine in treatment algorithms

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a group of oral hypoglycemic agents used to manage Type 2 Diabetes Mellitus, which is a significant risk factor for coronary disease, heart failure, stroke, and many other cardiovascular conditions

Angiogenesis begins with the erosion of the basement membrane by enzymes released by endothelial cells and leukocytes

Until the GLP-1 shortage ends, drugmakers will have to balance commercial impact of this parallel marketplace against legal costs of winning trademark infringement, and larger drug patent / IP disputes